RESUMO
Paracoccidioidomycosis (PCM) is a systemic mycosis with serious clinical consequences in which the use of antifungal drugs requires long-term treatment. Therefore, we studied the effect of low-level LASER therapy (LLLT) to evaluate its prospects as a complementary treatment for PCM and improve the clinical response to the disease. OBJECTIVES: Our study focused on the resolution of lesions caused by fungal infection using a subcutaneous air pouch model of infection. METHODS: We evaluated cell profile and cytokines, fungi viability, and the presence of fibroblasts and fibrocytes at the site of infection. Inoculation of P. brasiliensis (Pb) was performed using a subcutaneous air pouch model and the LLLT irradiation was performed on alternate days on the rear paws of mice for 10 days, after which the cells from the air pouch were collected and analyzed. RESULTS: In animals irradiated with LLLT, the influx of cells to the air pouch was reduced, but they were more activated and produced pro-inflammatory (IL-12, IL-17 and TNF-α) and neutrophil (PMN) activating cytokines (IL-8, GM-CSF and γ-IFN). A better resolution of the infection, evidenced by the reduction in the number of viable fungi with preserved morphology in the air pouch, and an increase in the number of fibrocytes, indicating a healing profile were also observed. CONCLUSION: LLLT decreased the influx of PMN, but those presents were highly activated, with increased fungicidal activity. LLLT irradiation also resulted in earlier cicatrization at the site of infection, leading to a better outcome of the infection. These data are favorable to the use of LLLT as a complementary therapy in PCM.
Assuntos
Citocinas , Terapia com Luz de Baixa Intensidade , Paracoccidioidomicose , Células Th1 , Células Th2 , Animais , Camundongos , Citocinas/metabolismo , Células Th1/imunologia , Células Th1/metabolismo , Paracoccidioidomicose/radioterapia , Paracoccidioidomicose/imunologia , Paracoccidioidomicose/patologia , Células Th2/imunologia , Células Th2/metabolismo , Paracoccidioides/imunologia , Camundongos Endogâmicos BALB C , MasculinoRESUMO
Paracoccidioidomycosis (PCM) caused by Paracoccidioides brasiliensis (Pb), is a severe mycosis, prevalent in tropical countries. The presence of polymorphonuclear neutrophils (PMN) in lesions is conspicuous, indicating their central role in innate immunity through the direct killing of Pb and the production of cytokines that activate acquired immunity in the presence of itraconazole (Itra). The toxicity and direct antifungal activity of Itra on Pb in splenocyte co-cultures were evaluated in vitro. Itra showed no toxic effect but marked antifungal activity against Pb. Purified PMN were obtained by the subcutaneous (SC) injection of Pb into mice. Results showed the effect of Itra on the size of the air pouch produced, the cellular population that migrated to the infection site, protein, and mitochondrial metabolism patterns, production of ROS an NO, and the number of cytokines synthesized. Lower doses (3 and 10 mg/kg) of Itra did not affect the cellular profile but led to a lower influx of viable more active PMN, and increased production of ROS and proteins. At a dose of 50 mg/kg the PMN profile remained unchanged along with all other parameters analyzed remained unaltered. Decreases in most cytokine levels were inversely proportional to the Itra concentration. Lower Itra concentrations may elicit activation of the immune response because the combined effects of therapy and immune response are needed, while the higher dose does not require it. Itra also promotes the activation of the cytokines which elicit PMN activation and consequently the resolution of Pb18 infection in the air pouch.
Assuntos
Neutrófilos , Paracoccidioidomicose , Animais , Camundongos , Neutrófilos/metabolismo , Paracoccidioidomicose/tratamento farmacológico , Paracoccidioidomicose/microbiologia , Itraconazol/farmacologia , Antifúngicos/farmacologia , Espécies Reativas de Oxigênio/metabolismo , Chumbo/metabolismo , Citocinas/metabolismo , Imunidade InataRESUMO
ETHNOPHARMACOLOGICAL RELEVANCE: Paracoccidioidomycosis (PCM) is a systemic mycosis with high prevalence in South America and especially in Brazil with severe clinical consequences that need broadened therapeutic options. Propolis is a natural resin from bees used in folk medicine for centuries with the first report in the ancient history of Egypt by Eberly papyrus, in Middle-Ages used to wash the newborn's umbilical cord and World War II as antiseptic or antibiotics. Nowadays it is a natural product worldwide consumed as food and traditionally used for oral and systemic diseases as an anti-inflammatory, antimicrobial, antifungal, and other diseases. Brazilian red propolis (BRP) is a new type of propolis with a distinguished chemical profile and biological activities from propolis (green) with pharmacological properties such as antimicrobial, anti-inflammatory, antioxidant, and others. AIM OF STUDY: Thus, the main purpose of this study was to investigate the direct in vitro and ex vivo effect of BRP on Paracoccidioides brasiliensis. MATERIAL AND METHODS: Antifungal activity of different concentrations of BRP on a virulent P. brasiliensis isolate (Pb18) was evaluated using the microdilution technique. Also, mice splenic cells co-cultured with Pb18 were treated with BRP at different times and concentrations (only Pb18 = negative control). Mice were inoculated with Pb18 and treated with different concentrations of BRP (50-500 mg/mL) in a subcutaneous air pouch. In this later experimental model, macroscopic characteristics of the air pouch were evaluated, and cellular exudate was collected and analyzed for cellular composition, mitochondrial activity, total protein reactive oxygen specimens (ROS), and nitric oxide production, as well as the number of viable fungal cells. RESULTS: The in vitro experiments showed remarkable direct antifungal activity of BRP, mainly with the highest concentration employed (500 mg/mL), reducing the number of viable cells to 10% of the original inoculum after 72 h incubation. The splenocytes co-cultivation assays showed that BRP had no cytotoxic effect on these cells, on the contrary, exerted a stimulatory effect. This stimulation was also observed on the PMNs at the air pouch, as verified by production of ROS and total proteins and mitochondrial activity. This activation resulted in enhanced fungicidal activity, mainly with the 500 mg/mL concentration of BRP. An anti-inflammatory effect was also detected, as verified by the smaller volume of the BRP-treated air pouch as well as by an earlier shift from neutrophils to mononuclear cells present in the infection site. CONCLUSION: Our results strongly suggest, for the first time in the literature, that Brazilian Red propolis has four protective mechanisms in experimental paracoccidioidomycosis: activating neutrophils, exerting a direct antifungal effect, preventing fungal dissemination, and controlling excessive inflammation process.
Assuntos
Antifúngicos/farmacologia , Paracoccidioides/efeitos dos fármacos , Paracoccidioidomicose/tratamento farmacológico , Própole/farmacologia , Animais , Antifúngicos/administração & dosagem , Antifúngicos/isolamento & purificação , Brasil , Modelos Animais de Doenças , Relação Dose-Resposta a Droga , Feminino , Inflamação/tratamento farmacológico , Inflamação/microbiologia , Camundongos , Neutrófilos/metabolismo , Paracoccidioidomicose/microbiologia , Própole/administração & dosagem , Própole/isolamento & purificação , Espécies Reativas de Oxigênio/metabolismoRESUMO
Sporotrichosis is a subcutaneous mycosis caused by traumatic inoculation into the skin by fungi species of the genus Sporothrix. The disease has different clinical manifestations (cutaneous, lymphocutaneous, and disseminated), and can also progress to a systemic infection. Despite having a worldwide distribution, sporotrichosis is most prevalent in tropical and subtropical countries. In Brazil, reports of the disease are higher frequent, where cases of the disease were found in Rio de Janeiro, Sao Paulo, Curitiba, Pernambuco, and Paraiba, among others. Certain groups of people may be more exposed to the causative agent of disease, such as residents of rural areas. Thus, this work aimed to carry out a seroepidemiological survey of the prevalence of sporotrichosis in four rural locations in the south of Minas Gerais State, Brazil. In this study, we used an indirect ELISA test in the survey on the prevalence of sporotrichosis. Data obtained in this study evaluated a population of 631 individuals and showed a prevalence of 44.69%. The distribution of seroprevalence of sporotrichosis with respect to age groups and gender showed no significant statistical difference. Thus, we found a high seroprevalence of sporotrichosis-infection in rural regions of southern Minas Gerais State, Brazil, with no difference in prevalence in relation to gender and age.
Assuntos
Anticorpos Antifúngicos/sangue , Sporothrix/imunologia , Esporotricose/sangue , Esporotricose/epidemiologia , Adolescente , Adulto , Distribuição por Idade , Idoso , Idoso de 80 Anos ou mais , Animais , Brasil/epidemiologia , Criança , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Prevalência , População Rural/estatística & dados numéricos , Estudos Soroepidemiológicos , Sporothrix/genética , Esporotricose/microbiologia , Adulto JovemRESUMO
Abstract Among the microorganisms that make up the intestinal microbiota, stands out Escherichia coli, which has as main ecological niche, the large human intestine. Its importance stands out in being part of the pioneer's commensal microorganisms on the colonization of the intestinal mucosa and its pathogenic role causing extra and intra intestinal diseases. The aim of the study was to evaluate the antibody production and proliferative response of Peripheral Blood Mononuclear Cells (PBMC) to E. coli antigens. The bacteria were grown on Brain Heart Infusion broth medium at 35 ºC for 72 hours. Pellet bacteria were lysed for one hour at room temperature with an 8M sodium guanidine solution. After spin and dialysis, the protein antigens were measured in the supernatant by protein assay. The antigens were characterized by polyacrylamide gel electrophoresis and the antigenic profile by western blotting. The presence of specific IgG and IgA antibodies were evaluated using thirty normal human sera by an indirect ELISA. The response of PBMC to E. coli antigens was assessed by MTT metabolization. The results demonstrated that the antigens were composed of proteins of different sizes and they were recognized by antibodies present in normal human serum. Human sera presented high titers of IgG and IgA antibodies to E. coli antigens when compared to the results of lipopolysaccharide. We also showed that total E. coli antigens induced PBMC proliferation at different antigen concentrations. Taken together the results suggest that the antigens from E. coli can induce local and systemic immune responses.
RESUMO
Fungal infections have been increasing in recent decades, mainly affecting immunocompromised individuals, although certain mycoses, such as paracoccidioidomycosis (PCM), infect immunologically competent individuals. The major problems observed regarding fungal diseases are inadequate diagnosis, prolonged treatment time, the reduced number of drugs available for treatment, in addition to the fact that there are no vaccines for clinical use. Drug combination in order to immunomodulate the immune response is a new strategy used for the treatment of mycoses, since it is difficult to develop new antifungal drugs. The aim of this study is to present and analyze strategies recently suggested for the treatment of fungi of medical interest, in particular for PCM, such as the utilization of combinations of protein fractions or dead microorganisms, as vaccinal antigens, and cellular immunotherapy. We will also propose new therapeutic alternatives, such as lipids, vitamins, synthetic or natural products as well as the use of low intensity LASER therapy (LLLT) to modulate the immune response of the host, enhancing the efficiency of the existing treatments of mycoses of medical interest and in particular of PCM.
Assuntos
Antifúngicos/uso terapêutico , Imunomodulação , Paracoccidioidomicose/tratamento farmacológico , Humanos , Imunoterapia , Paracoccidioidomicose/imunologiaRESUMO
Paracoccidiodomycosis (PCM) is a systemic mycosis caused by the fungus Paracoccidioides brasiliensis and Paracoccidioides lutzii. The disease requires long and complicated treatment. The aim of this review is to address the fungal virulence factors that could be the target of the development of new drugs for PCM treatment. Virulence factors favoring the process of fungal infection and pathogenicity are considered as a microbial attribute associated with host susceptibility. P. brasiliensis has some known virulence factors which are 43 kDa glycoprotein (gp 43) which is an important fungal antigen, 70 kDa glycoprotein (gp 70), the carbohydrates constituting the fungal cell wall α-1,3, glucan and ß-1,3-glucan, cell adhesion molecules and the presence of melanin pigments. The discovery and development of drugs that interact with these factors, such as inhibitors of ß-1,3-glucan, reduced synthesis of gp 43, inhibitors of melanin production, is of great importance for the treatment of PCM. The study of virulence factors favors the understanding of pathogen-host relationships, aiming to evaluate the possibility of developing new therapeutic targets and mechanisms that these molecules play in the infectious process, favoring the design of a more specific treatment for this disease.
Assuntos
Paracoccidioides , Paracoccidioidomicose , Fatores de Virulência/metabolismo , Animais , Antifúngicos/uso terapêutico , Parede Celular/metabolismo , América Central/epidemiologia , Proteínas Fúngicas/metabolismo , Glucanos/metabolismo , Glicoproteínas/metabolismo , Interações Hospedeiro-Patógeno , Humanos , Melaninas/metabolismo , Paracoccidioides/efeitos dos fármacos , Paracoccidioides/isolamento & purificação , Paracoccidioides/metabolismo , Paracoccidioides/patogenicidade , Paracoccidioidomicose/epidemiologia , Paracoccidioidomicose/metabolismo , Paracoccidioidomicose/patologia , Paracoccidioidomicose/terapia , Prevalência , América do Sul/epidemiologiaRESUMO
Os produtos embutidos estão sendo cada vez mais consumidos pela população, devido sua praticidade e durabilidade, além disso, serem muito saborosos. Visando a saúde pública, todos os alimentos devem passar por uma rigorosa inspeção, para garantir que o alimento chegue à mesa do brasileiro com toda garantia e qualidade. Foram pesquisadas cinco marcas de salames provenientes de supermercados e feiras livres da cidade de Alfenas MG, analisadas em duplicata, com duas repetições, sendo essas repetições feitas em intervalos e lotes diferentes para observação da qualidade do produto. Os dados obtidos foram surpreendentes, onde 60% das amostras analisadas apresentaram-se impróprias para o consumo por albergarem Salmonella sp.
Assuntos
Animais , Bovinos , Contaminação de Alimentos/análise , Inspeção de Alimentos , Alimentos Industrializados , Microbiologia de Alimentos , Produtos da Carne/microbiologia , Salmonella/isolamento & purificação , Suínos , Brasil , Amostras de Alimentos , Listeria monocytogenes/isolamento & purificaçãoRESUMO
A planta Plectranthus ornatus Codd é originária dos países do Mediterrâneo e Oriente Próximo. Na medicina popular é indicada para males do fígado e problemas de digestão. É utilizada no tratamento para o controle da gastrite, na dispepsia, azia, mal-estar gástrico e ressaca. Este trabalho objetiva a avaliação antimicrobiana do extrato de P. ornatus, utilizando-se 15 microrganismos padronizados. Os testes antimicrobianos foram realizados em ágar Mueller Hinton pela técnica de poços. Foram utilizados os testes de microdiluição em caldo, para a determinação da concentração inibitória mínima (CIM) e semeadura, em placas contendo ágar Mueller Hinton para a concentração microbicida mínima (CMM). Os testes de microdiluição em caldo demonstraram que o extrato nas concentrações de 20,31; 325 e 650 mg/mL inibiu o crescimento bacterianode Bacillus cereus, Streptococcus pyogenes e Enterococcus faecalis, respectivamente. Para o fungo Saccharomyces cerevisiae os testes de microdiluição demonstraram inibi- ção do crescimento na concentração de 1.300 mg/mL. Para as demais cepas testadas, o extrato não demonstrou atividade. Em decorrência da crescente resistência múltipla microbiana aos antibióticos, pesquisas para o desenvolvimento de novos medicamentosque sejam economicamente viáveis e com margem de segurança efetiva têm ganhado espaço na comunidade científica.
Plectranthus ornatus Codd is a plant from Mediterranean and Near East countries. It is indicated for liver illnesses and digestion problems in popular medicine. It is used in the treatment for the control of gastritis, dyspepsia, heartburn, gastric discomfort, and hangover. This study aims to evaluate the antimicrobial activity in extracts of P. ornatus using 15 standardized micro-organisms. Antimicrobial tests were performed on Mueller Hinton agar through the technique of wells. Broth microdilution tests were used for the determination of the minimum inhibitory concentration (MIC), and seeding on plates containing Mueller Hinton agar for the determination of the minimum microbicide concentration (MMC). The broth microdilution tests demonstrated that the extract inhibited the growth of Bacillus cereus, Streptococcus pyogenes, and Enterococcus faecalis at the concentrations of 20.31, 325, and 650 mg/mL, respectively. The microdilution tests showed growth inhibition of Saccharomyces cerevisiae at a concentration of 1,300 mg/mL. The extract did not show inhibitory activity on the other tested strains. As a result of increased multiple resistances to antibiotics,microbial research in the development of new drugs that are economically viable and offer an effective safety margin have won space in the scientific community.